Rtw Investments as of June 30, 2023
Portfolio Holdings for Rtw Investments
Rtw Investments holds 62 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunocore Hldgs Ads (IMCR) | 6.9 | $362M | 6.0M | 59.96 | |
| Rocket Pharmaceuticals (RCKT) | 6.7 | $352M | 18M | 19.87 | |
| Alnylam Pharmaceuticals (ALNY) | 6.1 | $320M | 1.7M | 189.94 | |
| Axsome Therapeutics (AXSM) | 5.9 | $308M | 4.3M | 71.86 | |
| Ptc Therapeutics I (PTCT) | 5.6 | $294M | 7.2M | 40.67 | |
| Ultragenyx Pharmaceutical (RARE) | 4.7 | $249M | 5.4M | 46.13 | |
| Masimo Corporation (MASI) | 4.7 | $247M | 1.5M | 164.55 | |
| ACADIA Pharmaceuticals (ACAD) | 4.5 | $234M | 9.8M | 23.95 | |
| Penumbra (PEN) | 4.4 | $232M | 673k | 344.06 | |
| Bruker Corporation (BRKR) | 4.2 | $219M | 3.0M | 73.92 | |
| Argenx Se Sponsored Adr (ARGX) | 3.6 | $188M | 482k | 389.73 | |
| Establishment Labs Holdings Ord (ESTA) | 3.3 | $171M | 2.5M | 68.61 | |
| Mirati Therapeutics | 3.1 | $162M | 4.5M | 36.13 | |
| Thermo Fisher Scientific (TMO) | 2.9 | $152M | 290k | 521.75 | |
| Protagonist Therapeutics (PTGX) | 2.8 | $150M | 5.4M | 27.62 | |
| Natera (NTRA) | 2.4 | $127M | 2.6M | 48.66 | |
| Vericel (VCEL) | 2.4 | $124M | 3.3M | 37.57 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $118M | 3.5M | 33.93 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.1 | $112M | 6.8M | 16.48 | |
| Horizon Therapeutics Pub L SHS | 2.0 | $103M | 1.0M | 102.85 | |
| Cytokinetics Com New (CYTK) | 1.6 | $84M | 2.6M | 32.62 | |
| 10x Genomics Cl A Com (TXG) | 1.6 | $82M | 1.5M | 55.84 | |
| Avidity Biosciences Ord (RNA) | 1.4 | $74M | 6.7M | 11.09 | |
| Illumina (ILMN) | 1.3 | $71M | 376k | 187.49 | |
| Intuitive Surgical Com New (ISRG) | 1.1 | $58M | 170k | 341.94 | |
| Madrigal Pharmaceuticals (MDGL) | 1.0 | $51M | 222k | 231.00 | |
| Stoke Therapeutics (STOK) | 0.9 | $47M | 4.4M | 10.63 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $46M | 2.5M | 18.07 | |
| Axonics Modulation Technolog (AXNX) | 0.9 | $45M | 885k | 50.47 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.7 | $39M | 5.6M | 7.00 | |
| Scpharmaceuticals (SCPH) | 0.6 | $34M | 3.3M | 10.19 | |
| Cutera | 0.5 | $28M | 1.8M | 15.13 | |
| Merus N V (MRUS) | 0.5 | $28M | 1.1M | 26.33 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $26M | 2.2M | 11.87 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.5 | $26M | 500k | 51.00 | |
| Insmed Com Par $.01 (INSM) | 0.4 | $21M | 1.0M | 21.10 | |
| Acelyrin | 0.4 | $20M | 978k | 20.90 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $20M | 6.1M | 3.30 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.4 | $19M | 1.5M | 12.43 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $19M | 3.0M | 6.26 | |
| Guardant Health (GH) | 0.3 | $18M | 501k | 35.80 | |
| Outset Med | 0.3 | $18M | 809k | 21.87 | |
| Viking Therapeutics (VKTX) | 0.3 | $16M | 1.0M | 16.21 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $16M | 922k | 17.05 | |
| Roivant Sciences SHS (ROIV) | 0.3 | $16M | 1.6M | 10.08 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $12M | 655k | 18.75 | |
| Immunic (IMUX) | 0.2 | $11M | 4.3M | 2.51 | |
| Adicet Bio (ACET) | 0.2 | $10M | 4.2M | 2.43 | |
| Design Therapeutics (DSGN) | 0.2 | $9.8M | 1.6M | 6.30 | |
| Immatics SHS (IMTX) | 0.2 | $9.8M | 845k | 11.54 | |
| Milestone Pharmaceuticals (MIST) | 0.2 | $9.3M | 3.3M | 2.85 | |
| Apyx Medical Corporation (APYX) | 0.2 | $8.9M | 1.8M | 5.03 | |
| Urogen Pharma (URGN) | 0.2 | $8.9M | 858k | 10.35 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $8.6M | 1.7M | 5.05 | |
| Dermtech Ord ord (DMTKQ) | 0.1 | $7.1M | 2.7M | 2.60 | |
| Relmada Therapeutics (RLMD) | 0.1 | $5.2M | 2.1M | 2.46 | |
| Exagen (XGN) | 0.1 | $4.3M | 1.5M | 2.90 | |
| Akoya Biosciences (AKYA) | 0.0 | $2.5M | 338k | 7.39 | |
| Mersana Therapeutics | 0.0 | $2.0M | 615k | 3.29 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.3M | 128k | 10.53 | |
| Miromatrix Med | 0.0 | $779k | 445k | 1.75 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $67k | 350k | 0.19 |